China Small Molecule Healthcare Contract Manufacturing Market Size & Outlook
Related Markets
China small molecule healthcare contract manufacturing market highlights
- The China small molecule healthcare contract manufacturing market generated a revenue of USD 8,138.6 million in 2024 and is expected to reach USD 25,804.2 million by 2033.
- The China market is expected to grow at a CAGR of 13.9% from 2025 to 2033.
- In terms of segment, commercial was the largest revenue generating phase in 2024.
- Preclinical & Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Small molecule healthcare contract manufacturing market data book summary
| Market revenue in 2024 | USD 8,138.6 million |
| Market revenue in 2033 | USD 25,804.2 million |
| Growth rate | 13.9% (CAGR from 2025 to 2033) |
| Largest segment | Commercial |
| Fastest growing segment | Preclinical & Clinical |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Preclinical & Clinical, Clinical, Commercial |
| Key market players worldwide | Lonza Group Ltd, Catalent Inc, Recipharm, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, Cambrex, Siegfried Holding AG, Eurofins Scientific SE, PCI Pharma Services, CordenPharma |
Other key industry trends
- In terms of revenue, China accounted for 7.5% of the global small molecule healthcare contract manufacturing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China small molecule healthcare contract manufacturing market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 25,804.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Small Molecule Healthcare Contract Manufacturing Market Scope
Small Molecule Healthcare Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| PCI Pharma Services | View profile | 1001-5000 | Philadelphia, Pennsylvania, United States, North America | http://www.pciservices.com |
| Cambrex | View profile | 1001-5000 | East Rutherford, New Jersey, United States, North America | http://www.cambrex.com |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
China small molecule healthcare contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to small molecule healthcare contract manufacturing market will help companies and investors design strategic landscapes.
Commercial was the largest segment with a revenue share of 63.73% in 2024. Horizon Databook has segmented the China small molecule healthcare contract manufacturing market based on preclinical & clinical, clinical, commercial covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to China small molecule healthcare contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China small molecule healthcare contract manufacturing market databook
-
Our clientele includes a mix of small molecule healthcare contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China small molecule healthcare contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into China small molecule healthcare contract manufacturing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
China small molecule healthcare contract manufacturing market size, by phase, 2021-2033 (US$M)
China Small Molecule Healthcare Contract Manufacturing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
